COVID-19 Vaccine

Vaccination Information

covid-19-vacc-schedule.png

Everyone 6 months and older is eligible and encouraged to get a COVID-19 vaccine. Make sure you stay up to date with primary series doses and boosters. Click the image or the tabs to see CDC's vaccination schedule for your age and situation. 

Vaccination Schedule for Most People

(People who are NOT Moderately or Severely Immunocompromised)

6 months-4 years

Moderna 
  • Total doses: 2
  • Primary series: 2 doses (4-8 weeks between doses)
  • Booster dose: Not currently authorized

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어Монгол, Pусский中文(简体), ไทย, Tiếng Việt

Pfizer-BioNTech 

  • Total doses: 3
  • Primary series: 3 doses (3-8 weeks between doses 1 and 2; at least 8 weeks between doses 2 and 3) 
  • Booster dose: Not currently authorized

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

5-11 years

Moderna 
  • Total doses: 2
  • Primary series: 2 doses (4-8 weeks between doses) 
  • Booster dose: Not currently authorized

6 Months-5 Years Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

6-11 Years Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

Pfizer-BioNTech 
  • Total doses: 3
  • Primary series: 2 doses (3-8 weeks between doses) 
  • Booster dose: 1 original (monovalent) booster 5 or more months after the primary series. Updated (bivalent) booster dose is not currently authorized.

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

12 years-Adult

Moderna
  • Total doses: 3 or more
  • Primary series: 2 doses (4-8 weeks between doses) 
  • Booster dose: 1 updated (bivalent) booster* 2 or more months after either:
  • completing the 2-dose primary series -OR-
  • previously received monovalent booster dose(s) 

*Children and teens (ages 12-17 years) can only receive a Pfizer-BioNTech bivalent booster.

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

 Pfizer-BioNTech

  • Total doses: 3 or more
  • Primary series: 2 doses (3-8 weeks between doses) 
  • Booster dose: 1 updated (bivalent) booster* 2 or more months after either:
  • completing the 2-dose primary series -OR-
  • previously received monovalent booster dose(s) 

*Children and teens (ages 12-17 years) can only receive a Pfizer-BioNTech bivalent booster.

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

 Novavax

  • Total doses: 3
  • Primary series: 2 doses (3-8 weeks between doses) 
  • Booster dose: 1 updated (bivalent) booster* 2 or more months after completing the 2-dose primary series. Novavax is not currently authorized as a booster. 

*Children and teens (ages 12-17 years) can only receive a Pfizer-BioNTech bivalent booster.

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

J&J (Janssen) Recipients

Johnson and Johnson (Janssen)
  • Total doses: 2 or more
  • Primary series: 1 dose 
  • Booster dose: 1 updated (bivalent) booster 2 or more months after either:
  • completing the 1-dose primary series -OR-
  • previously received monovalent booster dose(s) 

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

Scroll below to view the vaccine schedule for people who are moderately or severely immunocompromised.


Vaccination Schedule for People who are Moderately or Severely Immunocompromised

This section is for people who are moderately or severely immunocompromised. The immune response following COVID-19 vaccination may differ in people who are moderately or severely immunocompromised at the time of vaccination. CDC has specific guidance for this population as described below.

6 months-4 years

Moderna
  • Total doses: 3
  • Primary series: 3 doses (4 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)
  • Booster dose: Not currently authorized

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

Pfizer-BioNTech 
  • Total doses: 3
  • Primary series: 3 doses (3 weeks between doses 1 and 2; at least 8 weeks between doses 2 and 3) 
  • Booster dose: Not currently authorized

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Vit

5-11 years

Moderna
  • Total doses: 3
  • Primary series: 3 doses (4 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)
  • Booster dose: Not currently authorized

6 Months-5 Years Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

6-11 Years Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

Pfizer-BioNTech
  • Total doses: 4
  • Primary series: 3 doses (3 weeks between doses 1 and 2; at least 8 weeks between doses 2 and 3) 
  • Booster dose: 1 original (monovalent) booster 3 or more months after the primary series. Updated (bivalent) booster dose is not currently authorized.

Vaccine Fact SheetEnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

12 years-Adult

Moderna
  • Total doses: 4 or more
  • Primary series: 3 doses (4 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)
  • Booster dose: 1 updated (bivalent) booster* 2 or more months after either:
    • completing the 3-dose primary series -OR-
    • previously received monovalent booster dose(s) 

    *Children and teens (ages 12-17 years) can only receive a Pfizer-BioNTech bivalent booster.

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

Pfizer-BioNTech

  • Total doses: 4 or more
  • Primary series: 3 doses (3 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3) 
  • Booster dose: 1 updated (bivalent) booster* 2 or more months after either:
  • completing the 3-dose primary series -OR-
  • previously received monovalent booster dose(s) 

*Children and teens (ages 12-17 years) can only receive a Pfizer-BioNTech bivalent booster.

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

Novavax

  • Total doses: 3
  • Primary series: 2 doses (3 weeks between doses) 
  • Booster dose: 1 updated (bivalent) booster* 2 or more months after completing the 2-dose primary series. Novavax is not currently authorized as a booster. 

*Children and teens (ages 12-17 years) can only receive a Pfizer-BioNTech bivalent booster.

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

J&J (Janssen) Recipients

Johnson and Johnson (Janssen)
  • Total doses: 3 or more
  • Primary series: 1 dose of Johnson & Johnson
  • Additional dose: 1 dose of an mRNA vaccine at least 4 weeks after dose 1 
  • Booster dose: 1 updated (bivalent) booster 2 or more months after either:
  • completing the primary series and additional dose -OR-
  • previously received monovalent booster dose(s) 

Vaccine Fact Sheet: EnglishEspañolአማርኛالعربيةবাংলা한국어МонголPусский中文(简体)ไทยTiếng Việt

 

Additional Resources (lasted updated 6/24/2022)